Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
3.170
-0.010 (-0.31%)
At close: Mar 6, 2026, 4:00 PM EST
3.155
-0.015 (-0.48%)
After-hours: Mar 6, 2026, 6:47 PM EST
Cabaletta Bio Market Cap
Cabaletta Bio has a market cap or net worth of $305.16 million as of March 6, 2026. Its market cap has increased by 198.73% in one year.
Market Cap
305.16M
Enterprise Value
171.01M
1-Year Change
198.73%
Ranking
Category
Stock Price
$3.17
Market Cap Chart
Since October 25, 2019, Cabaletta Bio's market cap has increased from $235.53M to $305.16M, an increase of 29.56%. That is a compound annual growth rate of 4.15%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avalo Therapeutics | 320.46M |
| Greenwich LifeSciences | 319.90M |
| Protara Therapeutics | 316.16M |
| Nautilus Biotechnology | 312.61M |
| XOMA Royalty | 308.86M |
| Puma Biotechnology | 307.80M |
| C4 Therapeutics | 296.64M |
| Silence Therapeutics | 293.09M |